Literature DB >> 24171830

Scleral-fixated posterior chamber intraocular lens implantation in pediatric and adult patients.

Ayse Burcu1, Zuleyha Yalniz-Akkaya, Iskan Abay, Mehmet Akif Acar, Firdevs Ornek.   

Abstract

PURPOSE: To evaluate the results of scleral-fixated posterior chamber intraocular lenses (SFIOL) in pediatric and adult patients.
METHODS: We carried out a retrospective analysis of 129 eyes of 120 patients (adult group, n = 96; pediatric group, n = 24) who underwent SFIOL implantation. Outcome measures were indications, corrected distance visual acuity (CDVA), change in visual acuity, and complications.
RESULTS: The median follow-up time was six months (minimum: 6; maximum: 55 months). The median preoperative CDVAs were similar between the groups (p = 0,253). The median postoperative CDVA was 0.2 (min: hand motion; max: 0.8) in pediatric patients and 0.5 (min: hand motion; max: 1.0) in adult patients in decimal notation, (p = 0.017). The CDVA improved at least one Snellen line or remained unchanged in all pediatric eyes, and in 87 (90.6%) adult eyes. The change in visual acuity was similar between the groups (p = 0.296).
CONCLUSION: In both pediatric and adult patients, SFIOL implantation ends with favorable outcomes over the short term.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24171830     DOI: 10.3109/08820538.2013.835834

Source DB:  PubMed          Journal:  Semin Ophthalmol        ISSN: 0882-0538            Impact factor:   1.975


  3 in total

1.  Scleral fixation of a posterior chamber intraocular lens combined with penetrating keratoplasty in an aphakic patient with microcornea and microphthalmia.

Authors:  He J Li; Konstantinos T Tsaousis; Geoffrey C Tabin
Journal:  BMJ Case Rep       Date:  2016-04-06

2.  Scleral-Fixated Intraocular Lenses: Past and Present.

Authors:  Maxwell S Stem; Bozho Todorich; Maria A Woodward; Jason Hsu; Jeremy D Wolfe
Journal:  J Vitreoretin Dis       Date:  2017-03-02

3.  Sutureless Intrascleral Haptic-Hook Lens Implantation Using 25-Gauge Trocars.

Authors:  Zhi-Xiang Hu; HaiShuang Lin; Lingying Ye; Zhong Lin; Tianyu Chen; Ke Lin; Rong-Han Wu
Journal:  J Ophthalmol       Date:  2018-12-27       Impact factor: 1.909

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.